YL
Therapeutic Areas
Askgene Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ASKB589 | First-Line Advanced Gastric and Gastroesophageal Junction Cancers | Phase 3 |
Leadership Team at Askgene Pharma
J'
Jian-Feng 'Jeff' Lu, Ph.D.
President and CEO
MH
Matt Hsu, Ph.D.
Vice President of Preclinical and Clinical Pharmacology
RC
Ray Chuang, Ph.D.
Vice President of Cell Line Development
SS
Stone Shi, Ph.D.
Vice President of Purification/Analytical/Formulation